What are the treatment options for localized prostate cancer

For prostate cancer, "localized" means the cancer is found only within the prostate gland and has not spread to nearby tissues or distant parts of the body.

Standard Medical Guidance

When considering treatment options for localized prostate cancer, oncologists typically evaluate several factors. These include the patient's specific risk group (e.g., lower-risk, intermediate-risk, high-risk, very high-risk), their overall health, and their life expectancy. The goal is to choose an approach that effectively treats the cancer while minimizing side effects and maintaining quality of life.

According to NCCN Guidelines for Patients, standard treatment approaches for localized prostate cancer include:

1. Active Surveillance:

   • Description: This involves closely monitoring the cancer with regular PSA (prostate-specific antigen) blood tests, digital rectal exams, and sometimes repeat biopsies or imaging. The goal is to avoid or delay active treatment until there are signs that the cancer is growing or becoming more aggressive.
   • Clinical Reasoning: Active surveillance is often the preferred strategy for most patients with lower-risk prostate cancer and a longer life expectancy (more than 10 years), as many low-risk cancers grow very slowly or may never cause problems. [NCCN Guidelines for Patients: Early-Stage Prostate Cancer, Section 49, 56]
   • When Treatment Might Be Considered: If monitoring shows the cancer is progressing (e.g., an increase in Grade Group on biopsy, tumor size increase, or rising PSA), active treatment may then be recommended. [NCCN Guidelines for Patients: Early-Stage Prostate Cancer, Section 37]

2. Observation (Watchful Waiting):

   • Description: Similar to active surveillance, observation involves monitoring the cancer and watching for symptoms. However, it is a less aggressive approach, typically involving occasional PSA tests and physical exams, without regular biopsies. If symptoms develop, treatment often focuses on palliative care (symptom relief) rather than trying to cure the cancer.
   • Clinical Reasoning: Observation is generally recommended for older or frail patients with intermediate-risk prostate cancer and shorter life expectancies (5 to 10 years), or for patients with lower-risk prostate cancer and a short life expectancy (5 years or less) who have other serious health problems. [NCCN Guidelines for Patients: Early-Stage Prostate Cancer, Section 37]

3. Surgery (Radical Prostatectomy):

   • Description: A radical prostatectomy is a surgical procedure to remove the entire prostate gland, along with surrounding tissue and seminal vesicles. In some cases, nearby lymph nodes in the pelvis may also be removed (pelvic lymph node dissection, or PLND). The goal is to remove all cancer cells, aiming for negative surgical margins (no cancer cells found at the edges of the removed tissue).
   • Clinical Reasoning: This is a highly effective way of curing prostate cancer. It may be an option for patients with favorable intermediate-risk, high-risk, or certain very-high-risk prostate cancers, especially if they are expected to live 10 years or more (for intermediate-risk) or more than 5 years (for high-risk). [NCCN Guidelines for Patients: Early-Stage Prostate Cancer, Section 49, 56, 61]
   • Additional Treatment: After surgery, if there are signs that not all cancer was removed or if cancer has spread to lymph nodes, additional